Quick Answer
CervoMed Inc. reported Stockholders Equity of $18.22 million for fiscal year 2025.
CervoMed Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $18.22M | -53.5% |
| 2024 | $39.20M | +431.4% |
| 2023 | $7.38M | +122.2% |
| 2022 | -$33.29M | -195.3% |
| 2021 | $34.91M | +40.7% |
| 2020 | $24.81M | +23.2% |
| 2019 | $20.13M | +29.0% |
| 2018 | $15.61M | -26.5% |
| 2017 | $21.23M | +131.1% |
| 2016 | $9.18M | +22166.4% |
| 2015 | -$41.6K | -100.1% |
| 2014 | $38.17M | +490.9% |
| 2013 | $6.46M | +135.1% |
| 2012 | -$18.39M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $26.01M | -43.0% | -22.2% |
| June 30, 2025 | $33.44M | -33.1% | -3.4% |
| March 31, 2025 | $34.63M | +549.0% | -11.7% |
| December 31, 2024 | $39.20M | +431.4% | -14.1% |
| September 30, 2024 | $45.64M | +376.7% | -8.7% |
| June 30, 2024 | $49.98M | +242.3% | +836.5% |
| March 31, 2024 | $5.34M | +115.8% | -27.7% |
| December 31, 2023 | $7.38M | +122.2% | -23.0% |
- CervoMed Inc. showed a decrease of -53.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, CervoMed Inc.’s stockholders equity has grown by 199.1% (from -$18.39 million to $18.22 million).
- The most recent figure is from CervoMed Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: